Increased ALZ-50 immunoreactivity in CSF of pseudotumor cerebri patients

Annals of Clinical and Laboratory Science

Volumn 36, Issue 2, 2006, Pages 151-156

  Peng, Jeng Hsiung F ^d   Kung, Fei Tau ^a   Peng, Warner ^b   Parker Jr , Joseph C ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c University of Louisville School of Medicine   (United States)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

Author keywords

ALZ 50; CSF; Glial fibrillary acidic protein; Microtubule associated protein; Tau protein

Indexed keywords

ALZ 50 IMMUNOREACTIVE PROTEIN; CYTOSKELETON PROTEIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MONOCLONAL ANTIBODY ALZ 50; TAU PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALZHEIMER DISEASE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BRAIN HOMOGENATE; BRAIN PSEUDOTUMOR; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; CYTOSKELETON; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; EVALUATION; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOREACTIVITY; INTRACRANIAL HYPERTENSION; MALE; PAPILLEDEMA; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WESTERN BLOTTING;

ANTIGENS; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PSEUDOTUMOR CEREBRI;

EID: 33646526067     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Ahlskog JE, O'Neill BP. Pseudotumor cerebri. Ann Intern Med 1982;97:249-256.
2. Albrechtson ME, von Gerstenberg AC, Brocl, E. Mouse monoclonal antibodies reacting with human brain glial fibrillary acidic protein. J Neurochem 1984;42:86-93.
3. Brandt R. The tau proteins in neuronal growth and development. Front Biosci 1984;1:118-130.
4. Chandra V, Bellur SN, Anderson RJ. Low CSF protein concentration in idiopathic pseudotumor cerebri. Ann Neurol 1991;19:80-82.
5. Cleveland DW, Hwo SY, Kirschner MW. Purification of tau, microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol 1977;116:207-225.
6. Corbett JJ. Problems in the diagnosis and treatment of pseudotumor cerebri. Can J Neurol Sci 1983;10:221-229.
7. Davidson P, Sjogren, M. The use of proteomics in biomarker discovery in neurodegenerative disease. Dis Markers 2005;21:81-92.
8. Davison PF, Jones RN. Filament proteins in central, cranial, and peripheral mammalian nerves. J Cell Biol 1981;88:67-72.
9. El Mouedden M, Vandermeeren M, Meert T, Mercken M. Development of a specific ELISA for the quantitative study of amino-terminally truncated beta-amyloid peptides. J Neurosci Meth 2005;145:97-105.
10. Greber S, Lubee G, Cairus N, Fountoulakis M. Decreased levels of synapcosomal associated protein 25 in the brain of patients with Down's syndrome and Alzheimer's disease. Electrophoresis 1999;20:928-934.
11. Groppa SA, Chekhonin VP. Specific brain antigens as the indicators of the blood-brain barrier permeability in Alzheimer's disease. Zh Nevropatol Psikhiatr Im S S Korsakova 1991;91:50-52.
12. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayams S, Toda H, Kimura N, Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res 2005;80:120-128.
13. Johnston PK, Corbett JJ, Maxner CE. Cerebrospinal fluid protein and opening pressure in idiopathic intracranial hypertension (pseudotumor cerebri). Neurology 1991;41:1040-1042.
14. Kim H, Jensen CG, Rebhun, LI. The binding of MAP2 and tau on brain microtubules in vitro. Implications for microtubule structure. Ann NY Acad Sci 1986;466:218-225.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
16. Liu WK, Dickson DW, Yen SH. Heterogeneity of tau proteins in Alzheimer's disease. Am J Pathol 1993;142: 387-394.
17. Lowry OH, Rosebrough NJ, Farr NJ, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
18. Nicholas AP, Sambandam T, Echols JA, Tourtellotte WW. Increased citrullinated glial fibrillary acidic protein in secondary progressive multiple sclerosis. J Comp Neurol 2004;473:128-136.
19. Nielsen AL, Jorgensen AL. Self-assembly of the cytoskeletal glial fibrillary acidic protein is inhibited by an isoform-specific C terminus. J Biol Chem 2004;279: 41537-41545.
20. Norton WT, Aquino DA, Hozumil T, Chiu FC, Brosnan CF. Quantitative aspects of reactive gliosis: a review. Neurochem Res 1992;17:877-885.
21. Petzold A, Eikelenboom MJ, Gveric D, Keir G, Chapman M, Lazeron RH, Cuzner MI, Polman CH, Uitdehang BM, Thompson EJ, Giovannoni G. Markers for different glial cell response in multiple sclerosis: clinical and pathological correlations. Brain 2002;125:1462-1473.
22. Porchet R, Probst A, Bouras C, Draberova E, Draber P, Riederer BM. Analysis of glial acidic fibrillary protein in the human entorhinal cortex during aging and in Alzheimer's disease. Proteomics 2003;8:1476-1485.
23. Rye DB, Leverenz J, Greenberg SG, Davies P, Saper CB. The distribution of ALZ 50 immunoreactivity in the normal human brain. Neuroscience 1993;56:109-127.
24. Siegal NJ, Sparkman TG. Chronic hypervitaminosis A with intracranial hypertension and low cerebrospinal fluid concentration of protein. Clin Pediatr 1972;11:580-584.
25. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. PNAS USA 1979;76:4350-4354.
26. Uchihara T, Ysuchiya K, Kondo H, Hayama T, Ikeda, K. Widespread appearance of ALZ-50 immunoreactive neurons in the human brain with cerebral infarction. Stroke 1995;26:2145-2148.
27. Ueda K, Masliah E, Saitoh T, Bakalis SL, Scoble H, Kosik, KS. ALZ-50 recognizes a phosphorylated epitope of tau protein. J Neurosci 1990;10:3295-3304.
28. Umeda Y, Taniguchi S, Arima K, Piao YS, Takehashi H, Iwatsubo T, Mann D, Hasegawa, M. Alterations in human tau transcripts correlate with those of neurofilament in sporadic tauopathies. Neurosci Lett 2004; 359:151-154.
29. Weisberg LA. Benign intracranial hypertension. Medicine 1975;54:197-207.
30. Wolozin BL, Pruchnicki A, Dickson DW, Davies P. A neuronal antigen in the brains of Alzheimer's patients. Science 1986;232:648-650.